Aligos stockholders approve increase in authorized shares from 300M to 500M and amendment to 2020 incentive plan

Aligos Therapeutics, Inc.

Stockholders approved increase in authorized shares from 300M to 500M, effective June 27, 2024.
Approved amendment to 2020 incentive plan to treat pre-funded warrants with exercise price ≤ $0.01 as common stock for annual share increases.
Board authorized to effect reverse stock split if deemed in best interests; no immediate action.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.